Gland Pharma Cash Flow Annual

BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | Sector: Biotechnology & Drugs

2,858.90 -51.45 (-1.77%)Updated : 18 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-88.06	-75.88	-774.33	-0.29
Net Changein Cash	802.90	2,199.12	-1,551.81	1,590.08
Cash Taxes Paid	455.45	353.80	306.15	310.87
Net Income/ Starting Line	1,464.58	1,062.66	1,132.54	1,054.58
Total Cash Dividends Paid	-296.55	-329.49	-	-
Changesin Working Capital	-709.95	-359.87	-359.35	-728.81
Cashfrom Operating Activities	1,031.39	914.73	996.80	363.97
Cash Interest Paid	32.36	30.60	25.61	6.29
Cashfrom Financing Activities	-416.97	-433.48	-799.42	14.92
Depreciation/ Depletion	423.67	377.87	344.57	146.74
Other Investing Cash Flow Items Total	632.16	2,098.90	-1,358.66	1,431.31
Capital Expenditures	-494.43	-394.17	-398.26	-223.12
period Type	-	-	-	-
Foreign Exchange Effects	50.75	13.13	7.72	3.00
Non- Cash Items	-146.91	-165.94	-120.96	-108.54
Financing Cash Flow Items	-32.36	-30.60	-25.61	-6.29
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	137.73	1,704.74	-1,756.91	1,208.19
Issuance( Retirement)of Stock Net	-	2.49	0.53	21.50

*All figures in crores except per share values

Trending Stocks

1,241.00+11.00(0.89%)

267.80+1.75(0.66%)

3,416.00+16.00(0.47%)

2,630.25-64.75 (-2.40%)

323.00-7.55 (-2.28%)

Related News